News Headlines Article

Studies boost hopes for new class of cholesterol medicines
Modern Healthcare

New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market.

People taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given usual care—typically one of the statin drugs such as Lipitor or Zocor, doctors found.